《Modern Chemotherapy》

作品数：15被引量：11H指数：2
导出分析报告
《Modern Chemotherapy》
主办单位：美国科研出版社
最新期次：2014年2期更多>>
发文主题：METASTATICCHEMOTHERAPYUNRESECTABLEINTRAPERITONEALSECOND-LINE更多>>
发文领域：医药卫生更多>>
-
在结果中检索

检索结果分析

结果分析中...
共 条 记 录，以下是1-10
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Intraperitoneal Chemotherapy for Gastric Cancer with Peritoneal Carcinomatosis: Is HIPEC the Only Answer?被引量：3
《Modern Chemotherapy》2014年第2期11-19,共9页Ka-On Lam Betty Tsz-Ting Law Simon Ying-Kit Law Dora Lai-Wan Kwong 
Gastric cancer with peritoneal carcinomatosis is notorious for its dismal prognosis. While the pathophysiology of peritoneal dissemination is still controversial, the rapid downhill course is universal. Patients usual...
关键词：Gastric Cancer Peritoneal CARCINOMATOSIS Hyperthermic INTRAPERITONEAL CHEMOTHERAPY (HIPEC) NEOADJUVANT Intraperitoneal/Systemic CHEMOTHERAPY (NIPS) Cytoreductive Surgery 
Intraperitoneal distribution of alginate microcapsules in mice
《Modern Chemotherapy》2014年第1期1-4,共4页F.Dagbert Y.J.McConnell E.Carmona L.Sideris J.P.Hallé P.Dube 
Introduction: Improved drug delivery mechanisms for the treatment of residual peritoneal cancer cells following cytoreduction surgery are needed. Alginate microcapsules are a potentially useful mechanism for delivery ...
关键词：Alginate Microcapsule Peritoneal Cavity Peritoneal Carcinosis Thymidine Phosphorylase HIPEC CAPECITABINE 
Crizotinib in non-small cell lung cancer被引量：1
《Modern Chemotherapy》2014年第1期5-9,共5页Nawfel Mellas Fatimzahra Hijri Zineb Benbrahim Omar El Mesbahi Nabil Ismaili 
Chemotherapy and targeted therapy remain the cornerstone of treatment of locally advanced and metastatic non-small cells lung cancer (NSCLC). Given the intrinsic chemoresistance of tumor cells, new treatment options h...
关键词：NSCLC CRIZOTINIB METASTATIC NSCLC ALK CHEMOTHERAPY 
Allogeneic and autologous stem cell transplantation with busulfan, cyclophosphamide, and etoposide conditioning therapy for relapsed/refractory non-Hodgkin lymphoma
《Modern Chemotherapy》2013年第4期57-65,共9页Neelima Vidula Andrew M. Evens Irene B. Helenowski Borko Jovanovic Jane N. Winter Jayesh Mehta Seema Singhal Stephanie F. Williams Olga Frankfurt Jessica K. Altman Joanne Monreal Leo I. Gordon 
The optimal stem cell transplantation (SCT) conditioning therapy for relapsed/refractory non-Hodgkin lymphoma (NHL) is not clearly defined. In a retrospective analysis, we examined 25 patients with “high risk” relap...
关键词：Stem Cell Transplantation BUSULFAN CYCLOPHOSPHAMIDE ETOPOSIDE NON-HODGKIN Lymphoma 
An autopsy case of metastatic extramammary Paget’s disease treated with multimodality treatment including anti-HER2 therapy: What is the clinical and pathological significance of trastuzumab to the patient?被引量：1
《Modern Chemotherapy》2013年第4期66-68,共3页Noriko Yoshimura Koji Arihiro Shunsuke Takahagi Michihiro Hide 
Advanced Extramammary Paget’s disease (AEMPD) shows a poor prognosis despite multimodality therapy. In recent years, it is suggested that anti-HER2 therapy may be promising for HER2-positive AEMPD. We herein present ...
关键词：EXTRAMAMMARY Paget’s Disease HER2 AUTOPSY 
Uterine choriocarcinoma: A gynaecological masquerader case report and review of the literature
《Modern Chemotherapy》2013年第4期69-72,共4页Eguzo Kelech Chisara C. Umezurike Emmanuel Akwuruoha 
Background: Choriocarcinoma is a rare clinical condition, and its diagnosis may be difficult, especially in resource-limited settings. Case Presentation: A 38-year old para 2 woman is with a 4-month history of intract...
关键词：CHORIOCARCINOMA Chemotherapy Human Chorionic GONADOTROPIN RESOURCE-LIMITED SETTINGS 
CIMAvax^(█)EGF vaccine therapy for non-small cell lung cancer:A weighted log-rank tests-based evaluation
《Modern Chemotherapy》2013年第3期51-56,共6页Carmen Viada Gonzalez Jean-Francois Dupuy Martha Fors López Patricia Lorenzo Luaces Gisela González Marinello Elia Neninger Vinagera Beatriz García Verdecia Tania Crombet-Ramos 
supported by a UICC International Cancer Technology Transfer Fellowship.
Time-to-event has become one of the primary endpoints of many clinical trials. Comparing treatments and therapies using time-to-event (or “survival”) data requires some care, since survival differences may occur eit...
关键词：Log-Rank Test Fleming-Harrington Test Stratified Tests 
Extending the interval for port-a-cath maintenance
《Modern Chemotherapy》2013年第2期15-18,共4页Eugenia Girda Rebecca Phaeton Gary L. Goldberg Dennis Y. S. Kuo 
Objective: The objective of this study is to assess the outcome of port-a-cath (PAC) maintenance every three months in patients with gynecologic malignancies with the goal of standardizing a safe and appropriate inter...
关键词：INDWELLING PORT-A-CATH FLUSHING COMPLICATION Prevention 
Safety and efficacy of pemetrexed in gynecologic cancers: A systematic literature review被引量：1
《Modern Chemotherapy》2013年第2期19-32,共14页David Scott Miller Datchen Fritz Tai Coleman Obasaju Ignace Vergote 
Gynecologic cancers represent a significant problem worldwide. Advanced, recurrent gynecologic cancers are often refractory to chemo-therapy, so new treatment regimens are needed. Pemetrexed is a third-generation, mul...
关键词：PEMETREXED OVARIAN CERVICAL 
Drug therapy: Solamargine and other solasodine rhamnosyl glycosides as anticancer agents
《Modern Chemotherapy》2013年第2期33-49,共17页Bill E. Cham 
In the last century, the discovery of cytotoxic agents was revolutionary for anticancer therapy. These therapies have resulted in better understanding of cancer in general. However, the development of agents that comb...
关键词：CANCER Skin CANCER SOLAMARGINE Solasonine BEC SOLASODINE Rhamnosyl GLYCOSIDES CuradermBEC5 Apoptosis ANTINEOPLASTIC Targeted Therapy 
全选清除导出
共2页<12>
检索报告 对象比较 聚类工具 使用帮助 返回顶部